Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer: subgroup analyses of a Phase II study

BACKGROUND: The aim of the study was to conduct subgroup analyses of therapeutic effects of 12-month denosumab therapy on the percentage change in bone mineral density (BMD) from baseline in the lumber spine and femoral neck. MATERIALS AND METHODS: We prospectively evaluated the BMD of the lumbar sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakatsukasa, Katsuhiko, Koyama, Hiroshi, Ouchi, Yoshimi, Sakaguchi, Kouichi, Fujita, Yoshifumi, Matsuda, Takayuki, Kato, Makoto, Konishi, Eiichi, Taguchi, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044343/
https://www.ncbi.nlm.nih.gov/pubmed/30022834
http://dx.doi.org/10.2147/TCRM.S167579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044343/
https://www.ncbi.nlm.nih.gov/pubmed/30022834
http://dx.doi.org/10.2147/TCRM.S167579

Ejemplares similares